A panelist discusses how managing biosimilars requires close collaboration between payers and health systems to optimize patient care and cost savings, while sharing insights about program implementation challenges across different care settings and emphasizing the importance of robust operational frameworks.
Video content above is prompted by the following:
Get the latest industry news, event updates, and more from Managed healthcare Executive.